Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Chugai inks $250M deal for Gero’s age-related disease targets
Chugai offered up to $250 million for the chance to develop antibodies against age-related disease targets identified by Gero's AI-driven platform.
Nick Paul Taylor
Jul 7, 2025 3:00am
4DMT lays off 25% of workforce while phase 3 timeline ramps up
Jul 3, 2025 4:52am
Sponsored
SAP, Answerthink Help Emerging Biopharma Firms Scale
Jul 7, 2025 8:00am
Blocking enzyme saved mice from known Parkinson’s mechanism
Jul 2, 2025 5:26pm
Sponsored
Carl Sailer on AI, market trends, and strategic planning in biotech
Oct 28, 2024 8:00pm
Fierce Biotech Layoff Tracker 2025: 4DMT, Sage & more
Jul 2, 2025 3:15pm